[1]文良彥、尤之浩,終結白內障消除霧化的視覺,台北市:宏欣文化事業有限公司,2004。
[2]行政院衛生署,96年度全民健康保險醫療統計年報,台北:行政院衛生署,2007。
[3]吳萬益,企業研究方法(四版) ,台北市:華泰文化,2011。
[4]林人傑,青光眼病人視覺功能及健康相關生活品質之相關性探討,碩士論文,國立台灣大學醫療機構管理研究所,台北,2006。[5]林嘉理,先天與後天性色盲,財團法人尹書田紀念醫院,書田泌尿科眼科診所,2005。(cited 2011 Nov 26) Available from: URL: http://www.shutien.org.tw/0117_011.htm,造訪日期:2012/06/25。
[6]姚開屏,「簡介與評論常用的一般性健康相關生活品質量表兼談對未來研究的建議」,測驗年刊,第四十七卷,第二期,2000,第11-138頁。[7]姚開屏,「健康相關生活品質概念與測驗原理之簡介」,台灣醫學會雜誌,第六卷,第二期,2002,第183-192頁。[8]施永豐,「色盲乎? --色覺異常」,健康世界,第一百四十七卷,1998,第10-15頁。[9]柯玉潔,角膜厚度與弧度對眼壓測量值的影響,碩士論文,國立陽明大學醫學院臨床醫學研究所,台北,2004。[10]洪伯廷,青光眼的預防與保健,台北市:正中書局,1995。
[11]洪伯廷,淺說青光眼,台北市:宏欣文化,2003。
[12]張朝凱等,看見清楚與美麗:眼科疾病的治療保健與雷射近視手術,台北市:宏欣文化事業有限公司,2005。
[13]陳慕師,「糖尿病友發生視力障礙的原因」,糖尿病家族,第四卷,2002,第4-7頁。[14]曾旭民、盧瑞芬、蔡益堅,「國人生活品質評量:SF-36台灣版的常模與效度檢測」,台灣公共衛生雜誌,第二十二卷,第六期,2003,第512-518頁。[15]程景煜等,台灣地區老人視力與眼及現況,台中市:行政院衛生署國民健康局,2003。
[16]楊佳靜,青光眼量性預防醫學與成本效益評估,博士論文,臺灣大學公共衛生學院預防醫學研究所,台北,2008。[17]褚仁遠等,眼病學,中國北京:人民衛生出版社,2005。
[18]蔡景耀等,「社區老人視力障礙盛行率及其相關因子」,北市醫學雜誌,第1卷,2004,第344-351頁。
[19]邱宗聖, G. J. Johnson, “The Prevalence of Glaucoma in an Urban Chinese Population in Taiwan a Pilot Study,” 中華民國眼科醫學會雜誌, vol. 45, no. 2, 2006, pp. 63-75.
[20]U. Altangerel, G. L. Spaeth & D. J. Rhee, “Visual function, disability, and psychological impact of glaucoma,” Curr Opin Ophthalmol, vol. 14, no. 2, 2003, pp. 100-105.
[21]B. L. Barber, E. R. Strahlman, R. Laibovitz, H. A. Guess, S. A. Reines, “Validation of a questionnaire for comparing the tolerability of ophthalmic medications,” Ophthalmology, vol. 104, 1997, pp. 334-342.
[22]J. Burr, A. Azuara-Blanco, A. Avenell, Medical versus surgical interventions for open angle glaucoma, Cochrane Database of Systematic Reviews, 2005.
[23]J. H. Chen, L. Xu, A. L. Hu, B. C. Sun, J. J. Li, K. Ma, C. R. Xia, T. T. Cui, Y. Y. Zheng, Y. B. Li, R. X. Zhang, H. Yang, X. Y. Sun, Y. Zou, Y. Wang, B. R. Ma, “The prevalence and its effective factors of primary angle-closure glaucoma in defined populations of rural and urban in Beijing,” Zhonghua Yan Ke Za Zhi, vol. 83, 2003, 1413-1418.
[24]E. M. Chia, J. J. Wang, E. Rochtchina, W. Smith, O. R. Cumming, P. Mitchell, “Impact of Bilateral Visual Impairment on Health-Related Quality of Life: the Blue Mountains Eye Study,” Invest Ophthalmol Vis Sci, vol. 45, 2004, pp. 71-76.
[25]P. Desai, A. Reidy, D. C. Minassian, G. Vafidis, J. Bolger, “Gains from cataract surgery: visual function and quality of life,” Br J Ophthalmol, vol. 80, 1996, pp. 868-873.
[26]E. J. Duh, L. P. Aiello, Basic Pathobiology of the eye and its complications. Ellenberg & Rifkin''s Diabetes Mellitus, New York: McGraw-Hill, 2002.
[27]A. W. Foong, S. M. Saw, J. L. Loo, S. Shen, S. C. Loon, M. Rosman, T. Aung, D. T. Tan, E. S. Tai, T. Y. Wong, “Rationale and methodology for a population-based study of eye diseases in Malay people: The Singapore Malay eye study (SiMES),” Ophthalmic Epidemiology, vol. 14, 2007, pp. 25-35.
[28]P. J. Foster, R. Buhrmann, H. A. Quigley, G. J. Johnson, P. J. Foster, R. Buhrmann, H. A. Quigley, G. J. Johnson, “The definition and classification of glaucoma in prevalence surveys,” Br J Ophthalmol, vol. 86, 2002, pp. 238-242.
[29]Z. Gao, “An epidemiologic study of glaucoma in Tongcheng county, Anhui province,” Zhonghua Yan Ke Za Zhi, vol. 31, 1995, pp. 149-151.
[30]C. C. Geringer, N. R. Imami, “Medical management of glaucoma,” Int Ophthalmol Clin, vol. 48, 2008, pp. 115-141.
[31]C. A. Hazel, K. L. Petre, R. A. Armstrong, M. T. Benson, N. A. Frost, “Visual function and subjective quality of life compared in subjects with acquired macular disease,” Invest Ophthalmol Vis Sci, 41, 2000, pp. 1309-15.
[32]M. He, P. J. Foster, J. Ge, W. Huang, Y. Zheng, D. S. Friedman, P. S. Lee, P. T. Khaw, “Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan District, Guangzhou,” Invest Ophthalmol Vis Sci, vol. 47, 2006, pp. 278-282.
[33]R. Q. Ivers, R. Norton, R. G. Cumming, M. Butler, A. J. Campbell, “Visual impairment and risk of hip fracture,” Am J Epidemiol, vol. 152, 2000, pp. 633-9.
[34]N. K. Janz, P. A. Wren, P. R. Lichter, et al., “Quality of Life in newly diagnosed glaucoma patients: the Collaborative Initial glaucoma treatnment Study,” Ophthalmology, vol. 108, 2001, pp. 887-897.
[35]B. E. Klein, R. Klein, K. E. Lee, K. J. Cruickshanks, “Associations of performancebased and self-reported measures of visual function. The Beaver Dam Eye Study,” Ophthalmic Epidemiol, vol. 6, 1999, pp. 49-60.
[36]B. L. Lee, M. R. Wilson, “Health-related quality of life in patients with cataract and glaucoma,” J Glaucoma, vol. 9, no. 1, 2000, pp. 87-94.
[37]B. L. Lee, P. Gutierrez, M. Gordon, et al., “The Glaucoma Symptom Scale. A brief index of glaucoma – specific symptoms,” Arch Ophthalmol, vol. 116, 1998, pp. 861-866.
[38]J. H. Liu, C. Y. Cheng, S. J. Chen, F. L. Lee, “Visual impairment in a Taiwanese population: prevalence, causes, and socioeconomic factors,” Ophthalmic Epidemiol, vol. 8, 2001, pp. 339-350.
[39]C. Louis, S. B. Michael, A. H. Elizabeth, A. L. David, W. Roy, W. Martin, Glaucoma, “American Academy of Ophthalmology,” Basic and Clinical Science Course Section, 2000, pp. 7-8, pp. 11-13, pp. 104-127.
[40]C. M. Mangione, P. P. Lee, J. Pitts, et al., “Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators,” Arch Ophthalmol, vol. 116, no. 11, 1998, pp. 1496-1504.
[41]C. M. Mangione, P. P. Lee, J. Pitts, et al., “National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute visual function questionnaire,” Arch Ophthalmol, vol. 119, 2001, pp. 1050-1058.
[42]C. M. Mangione, R. S. Phillips, J. M. Seddon, et al., “Development of the “Activities of Daily Vision Scale,” A measure of visual function status. Medical Care, vol. 30, 1992, pp. 1111-1126.
[43]P. Nelson, P. Aspinall, C. O’Brien, “Patients’ perception of visual impairment in glaucoma: a pilot study,” Br J Ophthalmol, vol. 83, 1999, pp. 546-552.
[44]W. S. Ng, G. S. Ang, A. Azuara-Blanco, Laser peripheral iridoplasty for angle-closure, Cochrane Database Syst Rev, 2008.
[45]G. V. Padilla and M. M. Grant, “Quality of life as a cancer nursing outcome variable. ANS Adv Nurs Sci,” vol. 8, no. 1, 1985, pp. 45-60.
[46]S. Resnikoff, D. Pascolini, D. Etya''ale, I. Kocur, R. Pararajasegaram, G. P. Pokharel and S. P. Mariotti, “Global data on visual impairment in the year 2002,” Bulletin of the World Health Organization, vol. 82, no. 11, 2004, pp. 844-851.
[47]R. Ritch, C. C. Tham, D. S. Lam, “Argon laser peripheral iridoplasty (ALPI): an update,” Surv Ophthalmol, vol. 52, 2007, pp. 279-288.
[48]C. Rolim de Moura, A. Paranhos, Jr., R. Wormald, Laser trabeculoplasty for open angle glaucoma, Cochrane Database Syst Rev, 2007.
[49]E. Steinberg, J. Tielsch, O. Schein, et al., “The VF-14. An index of functional impairment in patients with cataract,” Arch Ophthalmol, vol. 112, 1994, pp. 630-638.
[50]D. S. Friedman, R. C. Wolfs, B. J. O''Colmain, B. E. Klein, H. R. Taylor, S. West, M. C. Leske, P. Mitchell, N. Congdon, J. Kempen, “Prevalence of open-angle glaucoma among adults in the United States,” Arch Ophthalmol, vol. 122, 2004, pp. 532-553.
[51]C. Y. Tsai, L. C. Woung, P. Chou, C. S. Yang, M. M. Sheu, J. R. Wu, T. L. Chuang, T. H. Tung, “The current status of visual disability in the elderly population of Taiwan,” Jpn J Ophthalmol, vol. 49, 2005, pp. 166-172.
[52]I. L. Tsai, L. C. Woung, C. Y. Tsai, L. L. Kuo, S. W. Liu, S. Lin and I. J. Wang, “Trends in blind and low vision registrations in Taipei City,” Eur J Ophthalmol, vol. 18, no. 1, 2008, pp. 118-124.
[53]C. Vass, C. Hirn, T. Sycha, O. Findl, P. Bauer, L. Schmetterer, Medical interventions for primary open angle glaucoma and ocular hypertension. Cochrane Database Syst Rev, 2007.
[54]M. Vetrugno, F. Cantatore, G. Ruggeri, P. Ferreri, A. Montepara, A. Quinto, C. Sborgia, “Primary open angle glaucoma: an overview on medical therapy,” Prog Brain Res, vol. 173, 2008, pp. 181-193.
[55]J. E. Ware Jr, “Conceptualizing disease impact and treatment outcomes,” Cancer, vol. 53, 1984, pp. 2316-23.
[56]I. B. Wilson, P. D. Cleary, “Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes,” JAMA, vol. 273, 1995, pp. 59-65.
[57]T. Y. Wong, S. C. Loon and S. M. Saw, “The epidemiology of age related eye diseases in Asia,” Br J Ophthalmol, vol. 90, no. 4, 2006, pp. 506-511.
[58]World Health Organization (WHO) (2012). Web Site (世界衛生組織網站), http://www.who.int/mediacentre/factsheets/fs282/en/index.html, 造訪時間:2012/06/25。
[59]L. Xu, L. Zhang, C. R. Xia, J. J. Li, L. N. Hu, K. Ma, Y. J. Chen, G. Z. Fan, W. X. Song, Y. Y. Shi, S. Y. Zhang, B. C. Sun. “The prevalence and its effective factors of primary angle-closure glaucoma in defined populations of rural and urban in Beijing,” Zhonghua Yan Ke Za Zhi, vol. 41, 2005, pp. 8-14.
[60]M. Zainal, S. M. Ismail, A. R. Ropilah, H. Elias, G. Arumugam, D. Alias, J. Fathilah, T. O. Lim, L. M. Ding, P. P. Goh, “Prevalence of blindness and low vision in Malaysian population: results from the National Eye Survey 1996,” Br J Ophthalmoll, vol. 86, 2002, pp. 951-956.
[61]J. Zhao, R. Sui, L. Jia, L. B. Ellwein, “Prevalence of glaucoma and normal intraocular pressure among adults aged 50 years or above in Shunyi county of Beijing,” Zhonghua Yan Ke Za Zhi, vol. 38, 2002, pp. 335-339.